#lenacapavir is an active hashtag on Bluesky. In the last 30 days, 18 people shared 67 posts with it — around 2 a day. Activity is down 62% versus the previous week, peaking on Jul 29 with 8 posts.

Posts with #lenacapavir

Whoa 🤯 in Slow-Mo

@0lsi.bsky.social

4 months ago

Kenya and Zimbabwe are among the first African countries to offer #lenacapavir, a game-changing #HIV prevention injection that's shown 100% efficacy 💉. You only need it twice a year. Kenya is already giving it out free at public clinics 🇰🇪, while Zimbabwe is rolling it out across 24 sites 🇿🇼.

www.rfi.fr

Kenya to offer patients free six-month HIV 'breakthrough' prevention jab

Kenya's health authorities have begun administering lenacapavir, a long-acting HIV prevention drug delivered by injection that offers protection for six months. The treatment will be available free of...

24 421 1677

Philip Baldwin

@philipcbaldwin.bsky.social

over 1 year ago

Really excited about the huge impact annual injectable #PrEP will have on reducing HIV transmissions. #Lenacapavir www.bbc.co.uk/news/article...

www.bbc.co.uk

Once-yearly jab for HIV protection passes first trial hurdle - BBC News

Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.

3 39 178

André Picard @picardonhealth

@picardonhealth.bsky.social

about 1 year ago

‘HIV-ending’ drug could be made for just $25 per patient a year: researchers. With #lenacapavir on verge of approval, campaigners urge manufacturer to make it ‘available and affordable for all who need it,’ by @katlay.bsky.social www.theguardian.com/socie…. via @theguardian.com #HIV #AIDS

www.theguardian.com

‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers

As regulator prepares to approve Lenacapavir in the US, campaigners are urging the manufacturer, Gilead, to make it ‘available and affordable for all who need it’

1 74 175

Mathias mit 1 Tee

@malo82.bsky.social

about 1 year ago

#Lenacapavir schützt 6 Monate effektiv vor einer Infektion mit #HIV. Gilead Sciences hat weltweit an 6 Generikahersteller Lizenzen für die Herstellung vergeben, um das Medikament in 120 Ländern mit niedrigem Einkommen zu verkaufen.

Science Magazine @science.org

Breaking news: The U.S. Food and Drug Administration has approved the drug lenacapavir as an HIV preventive. The approval comes at a time when global health cuts could stall its rollout. scim.ag/4e9FVSp

scim.ag

2 54 159

Federico Kukso

@fedkukso.bsky.social

over 1 year ago

Nuevo ensayo confirma que una inyección dos veces al año de #Lenacapavir tiene una eficacia del 96 % en la prevención del #VIH #PrEP Paper publicado hoy: www.nejm.org/doi/10.1056/...

www.nejm.org

Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons | NEJM

Twice-yearly subcutaneous lenacapavir has been shown to be efficacious for prevention of HIV infection in cisgender women. The efficacy of lenacapavir for preexposure prophylaxis (PrEP) in cisgende...

2 32 106

Celeste Moss

@celestevmoss.bsky.social

5 days ago

Did you know #lenacapavir only requires 2 injections per year to prevent HIV? Did you know its manufacturer @gilead.com is withholding it from middle-income countries where HIV is on the rise, including ones that participated in clinical trials and paved the way for the drug’s approval?

1 10 20

WHO

@who.int

9 months ago

⚠️ 1.3 million people acquired HIV in 2024 alone, including thousands of adolescent girls and young women. WHO recommends twice-yearly injectable #lenacapavir as a new effective pre-exposure prophylaxis (PrEP) option to protect people at risk of HIV. Know more: bit.ly/47gS2eV

1 43 83

AVAC

@avac.org

over 1 year ago

“The world would be crazy not to take full advantage of a tool that allows us to bring forward the end of #AIDS.” #PrEP #PEPFAR #Lenacapavir www.bloomberg.com/news/fe….

www.bloomberg.com

A ‘Miracle’ HIV Drug May Not Reach the Women Who Need It Most

Lenacapavir could be a gamechanger in the fight against infection. But US funding cuts have thrown the rollout of the twice-yearly injection into doubt.

1 37 83

Celeste Moss

@celestevmoss.bsky.social

3 days ago

@gilead.com I’m not sure if you are aware, but it’s very difficult to end the HIV epidemic for “everyone, everywhere” when you are withholding long-acting PrEP from places where HIV is on the rise. Drop the price of #lenacapavir to $40 for all low- and middle-income countries!

2 4 10

Liz Highleyman

@lizhighleyman.bsky.social

over 1 year ago

Science (@science.org) has named twice-yearly #lenacapavir #PrEP as its Breakthrough of the Year, recognizing it as a game-changer in the fight to end the #HIV epidemic worldwide. Aiming to further push the envelope, Gilead is now working on a once-yearly version. www.poz.com/article/twic...

www.poz.com

Twice-Yearly HIV PrEP Is the Breakthrough of the Year—Could It Be Annual?

Gilead is working on new formulations of injectable lenacapavir that could be administered just once a year.

3 11 52

Celeste Moss

@celestevmoss.bsky.social

21 days ago

This skit is brought to you by my Nerdfighter plushies Glennnn and Hanklerfish. I hope you like it! (5/5) @tbfighters.org @johngreensbluesky.bsky.social @hankgreen.bsky.social #2Shots$40Everywhere #lenacapavir #tbfighter #nerdfighter

1 3 43

Beanedict Cumbfurbatch

@beanedictc.dftba.social

7 days ago

@gilead.com likes to say, "For everyone, everywhere," but are Argentina, Brazil, Columbia, Mexico, and Peru not part of "everywhere"? Are people who can't pay $28k a year for HIV prevention not part of "everyone"? *Every*one should be able to get 2 shots of #lenacapavir for $40. #2Shots$40Everywhere

0 3 14